Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Towa Pharmaceutical Co ( (JP:4553) ) is now available.
Towa Pharmaceutical Co., Ltd. has announced changes in its executive structure following its Ordinary General Meeting of Shareholders and Board of Directors meeting. The reappointments include Itsuro Yoshida as President and Representative Director, and several other directors maintaining their positions, reflecting stability in the company’s leadership. These changes are aligned with the revised Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, indicating a continued focus on regulatory compliance.
The most recent analyst rating on (JP:4553) stock is a Buy with a Yen4200.00 price target. To see the full list of analyst forecasts on Towa Pharmaceutical Co stock, see the JP:4553 Stock Forecast page.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of generic drugs. The company is known for its commitment to ensuring the quality, efficacy, and safety of its pharmaceutical products.
Average Trading Volume: 133,946
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen143.6B
See more insights into 4553 stock on TipRanks’ Stock Analysis page.